Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of anti-tumor agents due to its ability to modulate signaling pathways in malignant cells. Also employed in the design of selective inhibitors for inflammatory and neurodegenerative diseases owing to its structural affinity for ATP-binding sites in enzymes. Commonly utilized in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and bioavailability.